These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21777198)

  • 1. Targeting aurora kinases in cancer treatment.
    Kelly KR; Ecsedy J; Mahalingam D; Nawrocki ST; Padmanabhan S; Giles FJ; Carew JS
    Curr Drug Targets; 2011 Dec; 12(14):2067-78. PubMed ID: 21777198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aurora-B kinase inhibitors for cancer chemotherapy.
    Yeung SC; Gully C; Lee MH
    Mini Rev Med Chem; 2008 Dec; 8(14):1514-25. PubMed ID: 19075809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurora B: a new prognostic marker and therapeutic target in cancer.
    Portella G; Passaro C; Chieffi P
    Curr Med Chem; 2011; 18(4):482-96. PubMed ID: 21143115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
    Matsuhashi A; Ohno T; Kimura M; Hara A; Saio M; Nagano A; Kawai G; Saitou M; Takigami I; Yamada K; Okano Y; Shimizu K
    Curr Cancer Drug Targets; 2012 Jul; 12(6):625-39. PubMed ID: 22463590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurora kinases: new targets for cancer therapy.
    Carvajal RD; Tse A; Schwartz GK
    Clin Cancer Res; 2006 Dec; 12(23):6869-75. PubMed ID: 17145803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aurora A and B kinases--targets of novel anticancer drugs.
    Libertini S; Abagnale A; Passaro C; Botta G; Portella G
    Recent Pat Anticancer Drug Discov; 2010 Nov; 5(3):219-41. PubMed ID: 20524930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with aurora kinase inhibitors: a review.
    Boss DS; Beijnen JH; Schellens JH
    Oncologist; 2009 Aug; 14(8):780-93. PubMed ID: 19684075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system.
    Pérez Fidalgo JA; Roda D; Roselló S; Rodríguez-Braun E; Cervantes A
    Clin Transl Oncol; 2009 Dec; 11(12):787-98. PubMed ID: 20045785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aurora kinase inhibitors as anticancer molecules.
    Katayama H; Sen S
    Biochim Biophys Acta; 2010; 1799(10-12):829-39. PubMed ID: 20863917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Aurora kinase family in cell division and cancer.
    Vader G; Lens SM
    Biochim Biophys Acta; 2008 Sep; 1786(1):60-72. PubMed ID: 18662747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurora kinase inhibitors.
    Kitzen JJ; de Jonge MJ; Verweij J
    Crit Rev Oncol Hematol; 2010 Feb; 73(2):99-110. PubMed ID: 19369091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Aurora-2 kinase in cancer.
    Warner SL; Bearss DJ; Han H; Von Hoff DD
    Mol Cancer Ther; 2003 Jun; 2(6):589-95. PubMed ID: 12813139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aurora kinases as an anti-cancer target.
    Ikezoe T
    Cancer Lett; 2008 Apr; 262(1):1-9. PubMed ID: 18294763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared and separate functions of polo-like kinases and aurora kinases in cancer.
    Lens SM; Voest EE; Medema RH
    Nat Rev Cancer; 2010 Dec; 10(12):825-41. PubMed ID: 21102634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Aurora-A inhibitors in cancer therapy.
    Agnese V; Bazan V; Fiorentino FP; Fanale D; Badalamenti G; Colucci G; Adamo V; Santini D; Russo A
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi47-52. PubMed ID: 17591831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurora kinase inhibitors in preclinical and clinical testing.
    Cheung CH; Coumar MS; Hsieh HP; Chang JY
    Expert Opin Investig Drugs; 2009 Apr; 18(4):379-98. PubMed ID: 19335272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapy.
    Jani JP; Arcari J; Bernardo V; Bhattacharya SK; Briere D; Cohen BD; Coleman K; Christensen JG; Emerson EO; Jakowski A; Hook K; Los G; Moyer JD; Pruimboom-Brees I; Pustilnik L; Rossi AM; Steyn SJ; Su C; Tsaparikos K; Wishka D; Yoon K; Jakubczak JL
    Mol Cancer Ther; 2010 Apr; 9(4):883-94. PubMed ID: 20354118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aurora kinase inhibitors: progress towards the clinic.
    Kollareddy M; Zheleva D; Dzubak P; Brahmkshatriya PS; Lepsik M; Hajduch M
    Invest New Drugs; 2012 Dec; 30(6):2411-32. PubMed ID: 22350019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of Aurora kinase inhibitors in cancer.
    Naruganahalli KS; Lakshmanan M; Dastidar SG; Ray A
    Curr Opin Investig Drugs; 2006 Dec; 7(12):1044-51. PubMed ID: 17209521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurora kinases: structure, functions and their association with cancer.
    Kollareddy M; Dzubak P; Zheleva D; Hajduch M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):27-33. PubMed ID: 18795071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.